Advertisement
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement
No AccessUrology PracticePatient Care1 Nov 2024

Initial Experience With Inpatient Hospital Care at Home for Urologic Disease

View All Author Information

Introduction:

In 2020, Mayo Clinic launched Advanced Care at Home (ACH), a hospital-at-home program that cares for high-acuity inpatients via remote monitoring and in-person care. Herein, we describe our initial experience utilizing ACH for patients with urologic problems.

Methods:

We identified ACH patients treated at Mayo Clinic Florida from July 2020 to August 2022. Records were reviewed to identify those with urologic problems, defined as genitourinary infections, urinary tract obstruction, bleeding, or complications following urologic surgery within 90 days of admission. Demographics, Charlson Comorbidity Index, ACH interventions, length of stay, and hospital readmission were assessed.

Results:

We identified 563 ACH admissions involving 537 patients, of whom 51 (9%) had illnesses with urologic etiology and 3 (0.6%) were admitted for nonurologic postoperative complications following urologic surgery. Admitting diagnoses included pyelonephritis (n = 51, 91%) and epididymoorchitis (n = 2, 4%). Postoperative diagnoses included cellulitis (n = 1, 2%), congestive heart failure (n = 1, 2%), and diverticulitis (n = 1, 2%). Median Charlson Comorbidity Index of admitted patients was 4 (interquartile range: 3-6.8). Twenty-five patients (46%) underwent 38 urologic procedures within 90 days of admission. Interventions included IV antibiotics (n = 51, 91%), IV fluids (n = 12, 21%), IV antifungals (n = 2, 4%), and oral diuretic therapy (n = 1, 2%). Median length of stay was 3 days (interquartile range: 2-4), and 9 patients (16%) were readmitted within 30 days. A total of 216 inpatient hospital days were saved by utilizing ACH.

Conclusions:

ACH appeared to be a feasible alternative to brick-and-mortar inpatient care for patients with genitourinary infections requiring IV antimicrobials.

References

Funding/Support: None.

Conflict of Interest Disclosures: Dr Lyon reports being a consultant/advisor for Bristol Myers Squibb, ImmunityBio, Urogen Pharma and a scientific study/trial investigator for Protara Therapeutics, Merck, Janssen, CG Oncology. Dr Thiel reports being an investigator for Grail, Inc. No other disclosures were reported.

Ethics Statement: This study was considered exempt by our Institutional Review Board (No. 23-003202).

Author Contributions:

Conception and design: Maniaci, Pathak, Hanchate, Pak, Lyon.

Critical revision of the manuscript for scientific and factual content: Thiel, Hanchate, Maniaci, Pathak, Pak, Lyon.

Drafting the manuscript: Hanchate, Pathak, Lyon.

Data analysis and interpretation: Thiel, Hanchate, Pak, Lyon.

Statistical analysis: Hanchate, Lyon.

Supervision: Thiel, Maniaci, Pathak, Pak, Lyon.

Data Availability: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.